DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0018798 | Congenital Heart Defects | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0015934 | Fetal Growth Retardation | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0017636 | Glioblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0020615 | Hypoglycemia | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0376358 | Malignant neoplasm of prostate | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C3887461 | Head and Neck Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0919267 | ovarian neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0011847 | Diabetes | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0020550 | Hyperthyroidism | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0271650 | Impaired glucose tolerance | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0740345 | Germ Cell Cancer | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0699790 | Colon Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0010068 | Coronary heart disease | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0004779 | Basal Cell Nevus Syndrome | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0019562 | Von Hippel-Lindau Syndrome | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0085207 | Gestational Diabetes | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C1621958 | Glioblastoma Multiforme | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0027708 | Nephroblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0027819 | Neuroblastoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0476089 | Endometrial Carcinoma | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0007133 | Carcinoma, Papillary | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0006118 | Brain Neoplasms | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0004997 | Benign Ovarian Neoplasm | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
C0020676 | Hypothyroidism | SLC2A3 | 6515 | solute carrier family 2 member 3 | P11169 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024